1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Immuno Oncology Assays Market, by Indication
6.1. Introduction
6.2. Bladder Cancer
6.3. Colorectal Cancer
6.4. Lung Cancer
6.5. Melanoma

7. Immuno Oncology Assays Market, by Product
7.1. Introduction
7.2. Consumables
7.3. Software

8. Immuno Oncology Assays Market, by Technology
8.1. Introduction
8.2. Flow Cytometry
8.3. Immunoassay
8.4. Ngs
8.5. PCR

9. Immuno Oncology Assays Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.3. Research

10. California Immuno Oncology Assays Market

11. Florida Immuno Oncology Assays Market

12. Illinois Immuno Oncology Assays Market

13. New York Immuno Oncology Assays Market

14. Ohio Immuno Oncology Assays Market

15. Pennsylvania Immuno Oncology Assays Market

16. Texas Immuno Oncology Assays Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Agilent Technologies, Inc.
18.2. Bio-Rad Laboratories, Inc
18.3. BioAgilytix Labs, LLC
18.4. Charles River Laboratories International, Inc.
18.5. Creative Biolabs, Inc.
18.6. ElsaLys Biotech SA
18.7. Eurofins DiscoverX Products, LLC
18.8. F. Hoffmann-La Roche AG
18.9. Foundation Medicine, Inc
18.10. HTG Molecular Diagnostics, Inc.
18.11. Illumina, Inc.
18.12. Merck KGaA
18.13. Nanostring Technologies, Inc.
18.14. NeoGenomics Laboratories, Inc
18.15. PerkinElmer, Inc.
18.16. QIAGEN GmbH
18.17. Sartorius AG
18.18. The General Electric Company
18.19. The Smithers Group Inc
18.20. Thermo Fisher Scientific, Inc.
18.21. Twist Bioscience Corporation

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2026
FIGURE 7. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 16. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2026
FIGURE 18. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 23. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 25. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NGS, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NGS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PCR, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PCR, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 34. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2026
FIGURE 36. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2026 (USD MILLION)
FIGURE 37. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 38. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, 2018-2026 (USD MILLION)
FIGURE 39. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 40. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: FPNV POSITIONING MATRIX
FIGURE 41. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 42. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NGS, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PCR, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: SCORES
TABLE 21. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: BUSINESS STRATEGY
TABLE 22. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: PRODUCT SATISFACTION
TABLE 23. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: RANKING
TABLE 24. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 25. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: MERGER & ACQUISITION
TABLE 26. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 27. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 28. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: INVESTMENT & FUNDING
TABLE 29. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 30. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET: LICENSE & PRICING

Companies Mentioned

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc
BioAgilytix Labs, LLC
Charles River Laboratories International, Inc.
Creative Biolabs, Inc.
ElsaLys Biotech SA
Eurofins DiscoverX Products, LLC
F. Hoffmann-La Roche AG
Foundation Medicine, Inc
HTG Molecular Diagnostics, Inc.
Illumina, Inc.
Merck KGaA
Nanostring Technologies, Inc.
NeoGenomics Laboratories, Inc
PerkinElmer, Inc.
QIAGEN GmbH
Sartorius AG
The General Electric Company
The Smithers Group Inc
Thermo Fisher Scientific, Inc.
Twist Bioscience Corporation